This report provides a comprehensive analysis of the global PCR-based Mycoplasma Testing Service market, which is projected to grow steadily through 2032. The study explores high-sensitivity testing technologies used for detecting contamination in biologics, vaccines, and cell therapies, offering a superior alternative to traditional culture methods. By examining key segments such as product release and contamination investigation, the research highlights major players, regional trends, and the evolving industrial chain supporting biopharmaceutical quality control and regulatory compliance.

Market Overview

The global PCR-based Mycoplasma Testing Service market size is predicted to grow from US$ 657 million in 2025 to US$ 904 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032.

Service Definition and Value Proposition

PCR-based Mycoplasma Testing Service refers to outsourced laboratory testing services that utilize PCR, qPCR, or RT-PCR technologies to detect mycoplasma contamination in cell cultures, biologics, vaccines, viral vectors, cell therapy products, raw materials, and research samples. The service provides rapid, sensitive, and specific detection by amplifying mycoplasma DNA or RNA targets.

Comparison with Traditional Methods: Compared with traditional culture-based methods, PCR-based testing offers:

• Shorter turnaround time
• Higher sensitivity
• Better suitability for biopharmaceutical quality control, cell bank release testing, GMP production monitoring, and contamination investigation.

Industry Chain Analysis

Upstream

• PCR reagents
• Primers
• Probes
• Nucleic acid extraction kits
• Enzymes
• Controls
• Sample tubes
• PCR instruments
• qPCR systems
• Laboratory consumables
• Cleanroom facilities
• Quality management systems

Midstream

• Sample receipt
• Nucleic acid extraction
• PCR amplification
• Assay validation
• Contamination control
• Result interpretation
• Report generation
• Data review
• Regulatory documentation

Downstream Applications

• Biopharmaceutical companies
• Vaccine manufacturers
• Cell and gene therapy developers
• Contract manufacturing organizations (CMOs)
• Cell banks
• Research institutes
• Diagnostic laboratories
• Academic laboratories

Related Services

• Method validation
• GMP testing
• Rapid release testing
• Deviation investigation
• Contamination source analysis
• Technical consulting

Regional Market Outlook

United States

The United States market for PCR-based Mycoplasma Testing Service is estimated to experience significant growth from 2025 through 2032.

China

The China market for PCR-based Mycoplasma Testing Service is estimated to undergo expansion between 2025 and 2032.

Europe

The Europe market for PCR-based Mycoplasma Testing Service is projected to increase in value from 2025 to 2032.

Market Segmentation

By Type

• Product Release Testing
• Contamination Investigation Testing
• Regulatory Compliance Testing
• Others

By Sample Type

• Cell Bank Testing
• Cell Culture Testing
• Others

By Application

• Biopharmaceutical Companies
• Contract Research/Manufacturing Organizations (CROs/CMOs)
• Universities and Research Institutions
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Global Players

• Charles River Laboratories International
• Thermo Fisher Scientific
• SGS
• Bionique Testing Laboratories
• WuXi AppTec
• Labcorp
• IDEXX BioAnalytics
• WiCell
• Creative Biogene
• Eurofins Scientific
• Hylabs
• JOINN Laboratories
• Shimadzu Diagnostics
• CellSafe
• FullHope Biomedical
• Syngene International
• Beyotime
• CTI Cert
• Shenke Bio

Market Concentration: In 2025, the global two largest companies occupied a significant portion of the total market revenue share.

Report Scope and Methodology

This LPI (LP Information) research report, titled “PCR-based Mycoplasma Testing Service Industry Forecast,” provides a comprehensive analysis of the global landscape.

Key Analytical Features:

• Historical & Forecast Data: Reviews total world sales in 2025 and provides a detailed analysis of projected sales for 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.
• Strategic Insights: Highlights key trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Competitive Intelligence: Analyzes the strategies of leading global companies, focusing on their portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• Market Drivers: Evaluates key market trends, drivers, and affecting factors shaping the global outlook to identify emerging pockets of opportunity.
• Methodology: Utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the industry.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global PCR-based Mycoplasma Testing Service Market Size (2021-2032)

    • 2.1.2 PCR-based Mycoplasma Testing Service Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for PCR-based Mycoplasma Testing Service by Country/Region (2021, 2025 & 2032)

  • 2.2 PCR-based Mycoplasma Testing Service Segment by Type

    • 2.2.1 Product Release Testing

    • 2.2.2 Contamination Investigation Testing

    • 2.2.3 Regulatory Compliance Testing

    • 2.2.4 Others

    • 2.2.5 PCR-based Mycoplasma Testing Service Market Size by Type

      • 2.2.5.1 PCR-based Mycoplasma Testing Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.5.2 Global PCR-based Mycoplasma Testing Service Market Size Market Share by Type (2021-2026)

  • 2.3 PCR-based Mycoplasma Testing Service Segment by Sample Type

    • 2.3.1 Cell Bank Testing

    • 2.3.2 Cell Culture Testing

    • 2.3.3 Others

    • 2.3.4 PCR-based Mycoplasma Testing Service Market Size by Sample Type

      • 2.3.4.1 PCR-based Mycoplasma Testing Service Market Size CAGR by Sample Type (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global PCR-based Mycoplasma Testing Service Market Size Market Share by Sample Type (2021-2026)

  • 2.4 PCR-based Mycoplasma Testing Service Segment by Application

    • 2.4.1 Biopharmaceutical Companies

    • 2.4.2 Contract Research/Manufacturing Organizations (CROs/CMOs)

    • 2.4.3 Universities and Research Institutions

    • 2.4.4 Others

    • 2.4.5 PCR-based Mycoplasma Testing Service Market Size by Application

      • 2.4.5.1 PCR-based Mycoplasma Testing Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.4.5.2 Global PCR-based Mycoplasma Testing Service Market Size Market Share by Application (2021-2026)

• 3 PCR-based Mycoplasma Testing Service Market Size by Player

  • 3.1 PCR-based Mycoplasma Testing Service Market Size Market Share by Player

    • 3.1.1 Global PCR-based Mycoplasma Testing Service Revenue by Player (2021-2026)

    • 3.1.2 Global PCR-based Mycoplasma Testing Service Revenue Market Share by Player (2021-2026)

  • 3.2 Global PCR-based Mycoplasma Testing Service Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 PCR-based Mycoplasma Testing Service by Region

  • 4.1 PCR-based Mycoplasma Testing Service Market Size by Region (2021-2026)

  • 4.2 Global PCR-based Mycoplasma Testing Service Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas PCR-based Mycoplasma Testing Service Market Size Growth (2021-2026)

  • 4.4 APAC PCR-based Mycoplasma Testing Service Market Size Growth (2021-2026)

  • 4.5 Europe PCR-based Mycoplasma Testing Service Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa PCR-based Mycoplasma Testing Service Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026)

  • 5.2 Americas PCR-based Mycoplasma Testing Service Market Size by Type (2021-2026)

  • 5.3 Americas PCR-based Mycoplasma Testing Service Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC PCR-based Mycoplasma Testing Service Market Size by Region (2021-2026)

  • 6.2 APAC PCR-based Mycoplasma Testing Service Market Size by Type (2021-2026)

  • 6.3 APAC PCR-based Mycoplasma Testing Service Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026)

  • 7.2 Europe PCR-based Mycoplasma Testing Service Market Size by Type (2021-2026)

  • 7.3 Europe PCR-based Mycoplasma Testing Service Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa PCR-based Mycoplasma Testing Service by Region (2021-2026)

  • 8.2 Middle East & Africa PCR-based Mycoplasma Testing Service Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa PCR-based Mycoplasma Testing Service Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global PCR-based Mycoplasma Testing Service Market Forecast

  • 10.1 Global PCR-based Mycoplasma Testing Service Forecast by Region (2027-2032)

    • 10.1.1 Global PCR-based Mycoplasma Testing Service Forecast by Region (2027-2032)

    • 10.1.2 Americas PCR-based Mycoplasma Testing Service Forecast

    • 10.1.3 APAC PCR-based Mycoplasma Testing Service Forecast

    • 10.1.4 Europe PCR-based Mycoplasma Testing Service Forecast

    • 10.1.5 Middle East & Africa PCR-based Mycoplasma Testing Service Forecast

  • 10.2 Americas PCR-based Mycoplasma Testing Service Forecast by Country (2027-2032)

    • 10.2.1 United States Market PCR-based Mycoplasma Testing Service Forecast

    • 10.2.2 Canada Market PCR-based Mycoplasma Testing Service Forecast

    • 10.2.3 Mexico Market PCR-based Mycoplasma Testing Service Forecast

    • 10.2.4 Brazil Market PCR-based Mycoplasma Testing Service Forecast

  • 10.3 APAC PCR-based Mycoplasma Testing Service Forecast by Region (2027-2032)

    • 10.3.1 China PCR-based Mycoplasma Testing Service Market Forecast

    • 10.3.2 Japan Market PCR-based Mycoplasma Testing Service Forecast

    • 10.3.3 Korea Market PCR-based Mycoplasma Testing Service Forecast

    • 10.3.4 Southeast Asia Market PCR-based Mycoplasma Testing Service Forecast

    • 10.3.5 India Market PCR-based Mycoplasma Testing Service Forecast

    • 10.3.6 Australia Market PCR-based Mycoplasma Testing Service Forecast

  • 10.4 Europe PCR-based Mycoplasma Testing Service Forecast by Country (2027-2032)

    • 10.4.1 Germany Market PCR-based Mycoplasma Testing Service Forecast

    • 10.4.2 France Market PCR-based Mycoplasma Testing Service Forecast

    • 10.4.3 UK Market PCR-based Mycoplasma Testing Service Forecast

    • 10.4.4 Italy Market PCR-based Mycoplasma Testing Service Forecast

    • 10.4.5 Russia Market PCR-based Mycoplasma Testing Service Forecast

  • 10.5 Middle East & Africa PCR-based Mycoplasma Testing Service Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market PCR-based Mycoplasma Testing Service Forecast

    • 10.5.2 South Africa Market PCR-based Mycoplasma Testing Service Forecast

    • 10.5.3 Israel Market PCR-based Mycoplasma Testing Service Forecast

    • 10.5.4 Turkey Market PCR-based Mycoplasma Testing Service Forecast

  • 10.6 Global PCR-based Mycoplasma Testing Service Forecast by Type (2027-2032)

  • 10.7 Global PCR-based Mycoplasma Testing Service Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market PCR-based Mycoplasma Testing Service Forecast

• 11 Key Players Analysis

  • 11.1 Charles River Laboratories International

    • 11.1.1 Charles River Laboratories International Company Information

    • 11.1.2 Charles River Laboratories International PCR-based Mycoplasma Testing Service Product Offered

    • 11.1.3 Charles River Laboratories International PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Charles River Laboratories International Main Business Overview

    • 11.1.5 Charles River Laboratories International Latest Developments

  • 11.2 Thermo Fisher Scientific

    • 11.2.1 Thermo Fisher Scientific Company Information

    • 11.2.2 Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Product Offered

    • 11.2.3 Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Thermo Fisher Scientific Main Business Overview

    • 11.2.5 Thermo Fisher Scientific Latest Developments

  • 11.3 SGS

    • 11.3.1 SGS Company Information

    • 11.3.2 SGS PCR-based Mycoplasma Testing Service Product Offered

    • 11.3.3 SGS PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 SGS Main Business Overview

    • 11.3.5 SGS Latest Developments

  • 11.4 Bionique Testing Laboratories

    • 11.4.1 Bionique Testing Laboratories Company Information

    • 11.4.2 Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Product Offered

    • 11.4.3 Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Bionique Testing Laboratories Main Business Overview

    • 11.4.5 Bionique Testing Laboratories Latest Developments

  • 11.5 WuXi AppTec

    • 11.5.1 WuXi AppTec Company Information

    • 11.5.2 WuXi AppTec PCR-based Mycoplasma Testing Service Product Offered

    • 11.5.3 WuXi AppTec PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 WuXi AppTec Main Business Overview

    • 11.5.5 WuXi AppTec Latest Developments

  • 11.6 Labcorp

    • 11.6.1 Labcorp Company Information

    • 11.6.2 Labcorp PCR-based Mycoplasma Testing Service Product Offered

    • 11.6.3 Labcorp PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Labcorp Main Business Overview

    • 11.6.5 Labcorp Latest Developments

  • 11.7 IDEXX BioAnalytics

    • 11.7.1 IDEXX BioAnalytics Company Information

    • 11.7.2 IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Product Offered

    • 11.7.3 IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 IDEXX BioAnalytics Main Business Overview

    • 11.7.5 IDEXX BioAnalytics Latest Developments

  • 11.8 WiCell

    • 11.8.1 WiCell Company Information

    • 11.8.2 WiCell PCR-based Mycoplasma Testing Service Product Offered

    • 11.8.3 WiCell PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 WiCell Main Business Overview

    • 11.8.5 WiCell Latest Developments

  • 11.9 Creative Biogene

    • 11.9.1 Creative Biogene Company Information

    • 11.9.2 Creative Biogene PCR-based Mycoplasma Testing Service Product Offered

    • 11.9.3 Creative Biogene PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Creative Biogene Main Business Overview

    • 11.9.5 Creative Biogene Latest Developments

  • 11.10 Eurofins Scientific

    • 11.10.1 Eurofins Scientific Company Information

    • 11.10.2 Eurofins Scientific PCR-based Mycoplasma Testing Service Product Offered

    • 11.10.3 Eurofins Scientific PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Eurofins Scientific Main Business Overview

    • 11.10.5 Eurofins Scientific Latest Developments

  • 11.11 Hylabs

    • 11.11.1 Hylabs Company Information

    • 11.11.2 Hylabs PCR-based Mycoplasma Testing Service Product Offered

    • 11.11.3 Hylabs PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Hylabs Main Business Overview

    • 11.11.5 Hylabs Latest Developments

  • 11.12 JOINN Laboratories

    • 11.12.1 JOINN Laboratories Company Information

    • 11.12.2 JOINN Laboratories PCR-based Mycoplasma Testing Service Product Offered

    • 11.12.3 JOINN Laboratories PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 JOINN Laboratories Main Business Overview

    • 11.12.5 JOINN Laboratories Latest Developments

  • 11.13 Shimadzu Diagnostics

    • 11.13.1 Shimadzu Diagnostics Company Information

    • 11.13.2 Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Product Offered

    • 11.13.3 Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Shimadzu Diagnostics Main Business Overview

    • 11.13.5 Shimadzu Diagnostics Latest Developments

  • 11.14 CellSafe

    • 11.14.1 CellSafe Company Information

    • 11.14.2 CellSafe PCR-based Mycoplasma Testing Service Product Offered

    • 11.14.3 CellSafe PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 CellSafe Main Business Overview

    • 11.14.5 CellSafe Latest Developments

  • 11.15 FullHope Biomedical

    • 11.15.1 FullHope Biomedical Company Information

    • 11.15.2 FullHope Biomedical PCR-based Mycoplasma Testing Service Product Offered

    • 11.15.3 FullHope Biomedical PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 FullHope Biomedical Main Business Overview

    • 11.15.5 FullHope Biomedical Latest Developments

  • 11.16 Syngene International

    • 11.16.1 Syngene International Company Information

    • 11.16.2 Syngene International PCR-based Mycoplasma Testing Service Product Offered

    • 11.16.3 Syngene International PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 Syngene International Main Business Overview

    • 11.16.5 Syngene International Latest Developments

  • 11.17 Beyotime

    • 11.17.1 Beyotime Company Information

    • 11.17.2 Beyotime PCR-based Mycoplasma Testing Service Product Offered

    • 11.17.3 Beyotime PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 Beyotime Main Business Overview

    • 11.17.5 Beyotime Latest Developments

  • 11.18 CTI Cert

    • 11.18.1 CTI Cert Company Information

    • 11.18.2 CTI Cert PCR-based Mycoplasma Testing Service Product Offered

    • 11.18.3 CTI Cert PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.18.4 CTI Cert Main Business Overview

    • 11.18.5 CTI Cert Latest Developments

  • 11.19 Shenke Bio

    • 11.19.1 Shenke Bio Company Information

    • 11.19.2 Shenke Bio PCR-based Mycoplasma Testing Service Product Offered

    • 11.19.3 Shenke Bio PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.19.4 Shenke Bio Main Business Overview

    • 11.19.5 Shenke Bio Latest Developments

• 12 Research Findings and Conclusion